View Alert

Originator: CMO Messaging

From: CMO Messaging

Issue date: Originally issued on 17-Apr-2020 16:43:03. This version was issued on 17-Apr-2020 16:43:03

This alert has been issued to:
  • NHS Regional Offices
  • NHS Foundation Trusts (England) - Medical Director
  • NHS Foundation Trusts (England) - Chief Executive
  • NHS Trusts (England) - Medical Director
  • NHS Trusts (England) - Chief Executive

  • Other contacts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • Social Care Providers (registered with CAS)
  • Special Health Authorities
  • CMO Urgent Messages - Non-NHS Recipients on Public Health Link
  • Territorial CMOs in Northern Ireland, Scotland & Wales
  • Regional Directors of Public Health
  • Consultants in Communicable Diseases
  • CMO Urgent Messages - Recipients on Public Health Link
  • Director of Public Health
  • GP - Locum
  • NHS 111 and Out of hours providers
  • GP Practices
  • Out of hours contacts
  • Primary Care Networks

Action category: Important information for immediate action

Title: NOTE THIS GUIDANCE HAS BEEN WITHDRAWN - Considerations for Personal Protective Equipment in the context of Acute Supply Shortages for Coronavirus Disease 2019 (COVID-19) Pandemic

Broadcast content:

THIS GUIDANCE HAS BEEN WITHDRAWN AS OF 09 SEPTEMBER WITH AN UPDATE ALERT CEM/CMO/2020/018(U) ISSUED ON 10 SEPTEMBER. This alert aims to highlight the sessional use and reuse of personal protective equipment (PPE) when there are severe shortages of supply.  

The considerations are to ensure that health and care workers are appropriately protected from COVID-19, where items of PPE are unavailable and should be considered as temporary measures until the global supply chain is adequate to meet the UKs needs.

The reuse of PPE should be implemented until confirmation of adequate re-supply is in place.

The attached alert contains further information.

Additional information: NHS England Regional Offices: please cascade to primary care providers in your areas.

Alert reference: CEM/CMO/2020/018


Contact our helpdesk


Medicines and Healthcare products Regulatory Agency